CN103494904A - Chinese medicine composition for treating neurasthenia - Google Patents

Chinese medicine composition for treating neurasthenia Download PDF

Info

Publication number
CN103494904A
CN103494904A CN201310467243.1A CN201310467243A CN103494904A CN 103494904 A CN103494904 A CN 103494904A CN 201310467243 A CN201310467243 A CN 201310467243A CN 103494904 A CN103494904 A CN 103494904A
Authority
CN
China
Prior art keywords
parts
chinese medicine
fructus
medicine composition
fruit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310467243.1A
Other languages
Chinese (zh)
Other versions
CN103494904B (en
Inventor
陈明玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310467243.1A priority Critical patent/CN103494904B/en
Publication of CN103494904A publication Critical patent/CN103494904A/en
Application granted granted Critical
Publication of CN103494904B publication Critical patent/CN103494904B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese medicine composition for treating neurasthenia. The traditional Chinese medicine believes that the neurasthenia belongs to the domains of 'insomnia', 'palpitation', 'melancholia', 'asthenic disease', 'spermatorrhea', 'erectile dysfunction' and the like, and is mainly caused by emotion injuries, spirit of overstrain, or dysfunctional organs after a serious illness and aeipathia. According to the Chinese medicine composition, the traditional Chinese medicines, such as oeder plagiopus herb, valerian, pinewood in poria, fragrant sarcococca fruit, obcordateleaf raspberry fruit, rust-coloured crotalaria herb with root, fructus akebiae, ferrosic oxide, henry melodinus fruit, glabrous ainsliaea herb, placenta hominis and liquorice, with the effects of nourishing liver and kidney, soothing liver, resolving depression, strengthening spleen, regulating vital energy, replenishing blood for nourishing heart, solidifying consciousness and calming the nerves, are selected to be decocted into decoction by water and taken orally. The total effective rate can be up to 92% by clinical observation; the Chinese medicine composition has no obvious toxic and side effects.

Description

A kind ofly treat neurasthenic Chinese medicine composition
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of neurasthenic Chinese medicine composition for the treatment of.
Background technology
The neurasthenia be a kind of take brain and somatic function weak in main neurosis, to be easy to excitement, being easy to again tired is feature, often with physiological function disorder symptoms such as the emotional symptoms such as anxiety, worry, irritability and muscular tone pain, sleep disorder.Clinical manifestation is that patient daytime is often sleepy, sleepy, weak, drowsiness, has a sleepless night night, dreaminess, has lost normal person's excitement and inhibition temporal regularity.There are some researches show, work, study hypertonicity are acted hurriedly in a messy situation, and have a rest and sleep and be irregular, and operating pressure is large, and health, in sub-health state and emotional instability etc., is to cause neurasthenic main cause.The western medical treatment neurasthenia mainly relies on to stabilize and waits the tranquilizer treatment of sleeping peacefully at present, but there is defect in these medicines aspect safety and dependency, easy addiction, drug resistance, and side effect is larger, unsuitable long-term taking.I find through clinical observation for many years, utilize the treatment by Chinese herbs neurasthenia to have curative effect preferably.
Summary of the invention
The purpose of this invention is to provide a kind of neurasthenic Chinese medicine composition for the treatment of.The traditional Chinese medical science thinks, the neurasthenia belongs to the categories such as " being insomnia ", " cardiopalmus ", " melancholia ", " deficient ", " seminal emission ", " sexual impotence ", how by feelings will hindered, after spiritual hypertonicity or serious disease prolonged illness due to visceral dysfunction.
The objective of the invention is to be achieved through the following technical solutions, this is treated neurasthenic Chinese medicine composition and is made by the Chinese medicine of following weight portion: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 7-9 part, Rhizoma et radix valerianae 8-10 part, Lignum Poria 6-12 part, Fructus sarcococcae ruscifoliae 8-12 part, Fructus Rubi obcordati 7-9 part, Herba Crotalariae Ferrugineae 7-11 part, Fructus Akebiae 7-9 part, pulvis ferri (ferrosic oxide) 7-12 part, Fructus Melodini Henryi 10-14 part, Herba Ainsliaeae Glabrae 10-14 part, Placenta Hominis 10-14 part, Radix Glycyrrhizae 6-10 part.
Preferably: 8 parts of Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.), 9 parts of Rhizoma et radix valerianaes, 9 parts of Lignum Porias, 10 parts of Fructus sarcococcae ruscifoliae, 8 parts of Fructus Rubi obcordatis, 9 parts of Herba Crotalariae Ferrugineaes, 8 parts of Fructus Akebiae, 9.5 parts of pulvis ferri (ferrosic oxide), 12 parts of Fructus Melodini Henryis, 12 parts of Herba Ainsliaeae Glabrae, 12 parts of Placenta Hominiss, 8 parts, Radix Glycyrrhizae.
Preparation method: by traditional preparation method decocting, make decoction.
In side: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.): tranquillizing and allaying excitement; Rhizoma et radix valerianae: tranquilizing by nourishing the heart, regulate the flow of vital energy, promoting blood circulation and stopping pain; Lignum Poria, Fructus sarcococcae ruscifoliae: nourishing the liver is calmed the nerves; Fructus Rubi obcordati: the kidney invigorating arresting seminal emission; Herba Crotalariae Ferrugineae: the gas of astringing the lung, spleen reinforcing kidney; Fructus Akebiae: liver-smoothing, qi-regulating, promoting blood circulation and stopping pain; Pulvis ferri (ferrosic oxide): checking hyperfunction of the liver for relieving convulsion, calmness, enrich blood; Fructus Melodini Henryi, Herba Ainsliaeae Glabrae: with blood dissipating blood stasis, yin nourishing; Placenta Hominis: benefiting QI and nourishing blood, the kidney warming are mended essence; Radix Glycyrrhizae: in the QI invigorating benefit, coordinating the actions of various ingredients in a prescription.
Clinical data
1. physical data selected 50 routine patients are the neurastheniac of my Out-patient Department and hospitalization, meet the relevant neurasthenic diagnostic criteria of CCMD mono-2-R, and are difficult to adhere to normal work, studying and living.Be divided at random two groups according to the sequencing of being admitted to hospital.Treatment group 25 examples, male 15 examples, female's 10 examples; 16~46 years old age, average 25.3 years old; The course of disease is the shortest 5 months, the longest 4.2 years, average 1.3 ± 0.8 years.Matched group 25 examples, male 13 examples, female's 12 examples; Age 16-45 year, average 23.6 years old; The course of disease is the shortest 6 months, the longest 3.6 years, average 1.2 ± 0.65 years.Two groups of data are relatively without significant difference.But have than property.
2. all cases of diagnostic criteria are all diagnosed with reference to neurasthenic diagnostic criteria in " neurological ".
3. two groups of patients of Therapeutic Method all give 1. general treatment: give estazolam 2mg, every day 3 times, the insomnia severe one adds to 4~6mg night; Oryzanol 20mg, every day 3 times; Piracetam 0.8g, every day 3 times; Accompany depressed person to give doxepin 25mg, every day 3 times.2. psychotherapy: adopt the method for individual psychotherapy, 1 time weekly, repeatedly to patient, explain the neurasthenic cause of disease, character and prognosis, analyze the poor reason of therapeutic effect in the past, by curing advising by citing one's own experience of case, patient is freed one's mind of apprehensions, establish confidence, actively partner treatment.The patient of church does the progressive relaxation training, and be 1-2 every day.Treatment group adds on the matched group basis uses new prescription: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 8g, Rhizoma et radix valerianae 9g, Lignum Poria 9g, 10 parts of g of Fructus sarcococcae ruscifoliae, Fructus Rubi obcordati 8g, Herba Crotalariae Ferrugineae 9g, Fructus Akebiae 8g, pulvis ferri (ferrosic oxide) 9.5g, Fructus Melodini Henryi 12g, Herba Ainsliaeae Glabrae 12g, 12 parts of g of Placenta Hominis, Radix Glycyrrhizae 8g, decocting becomes juice, instructions about how to take medicine: day potion, decoction being taken warmly at twice, serveing on 7 days was 1 course for the treatment of.
4. criterion of therapeutical effect recovery from illness: clinical symptom disappearance does not affect normal operation study.Produce effects: sleep quality improves, and appetite increases, and the diseases such as headache, dizziness, fatigue and weak are taken a turn for the better, hypermnesia.Effectively: above-mentioned symptom makes moderate progress.Invalid: before and after treatment, clinical symptoms is unchanged.
5. after two groups of patients of therapeutic outcome all treat 4 courses for the treatment of, treatment group total effective rate 92% is better than 68% of matched group, and difference has statistical significance (P<0.05), and concrete Comparison of therapeutic data are in Table 1.
Table 1 liang group Comparison of therapeutic
Figure BSA0000095988340000031
6. untoward reaction: do not find obvious adverse reaction.
The specific embodiment
Embodiment mono-: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 8g, Rhizoma et radix valerianae 9g, Lignum Poria 9g, 10 parts of g of Fructus sarcococcae ruscifoliae, Fructus Rubi obcordati 8g, Herba Crotalariae Ferrugineae 9g, Fructus Akebiae 8g, pulvis ferri (ferrosic oxide) 9.5g, Fructus Melodini Henryi 12g, Herba Ainsliaeae Glabrae 12g, 12 parts of g of Placenta Hominis, Radix Glycyrrhizae 8g, make decoction by traditional preparation method decocting.
Embodiment bis-: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 7g, Rhizoma et radix valerianae 8g, Lignum Poria 6g, Fructus sarcococcae ruscifoliae 8g, Fructus Rubi obcordati 7g, Herba Crotalariae Ferrugineae 7g, Fructus Akebiae 7g, pulvis ferri (ferrosic oxide) 7g, Fructus Melodini Henryi 10g, Herba Ainsliaeae Glabrae 10g, Placenta Hominis 10-g, Radix Glycyrrhizae 6g, make decoction by traditional preparation method decocting.
Embodiment tri-: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 9g, Rhizoma et radix valerianae 10g, Lignum Poria 12g, Fructus sarcococcae ruscifoliae 12g, Fructus Rubi obcordati 9g, Herba Crotalariae Ferrugineae 11g, Fructus Akebiae 9g, pulvis ferri (ferrosic oxide) 12g, Fructus Melodini Henryi 14g, Herba Ainsliaeae Glabrae 14g, Placenta Hominis 14g, Radix Glycyrrhizae 10g, make decoction by traditional preparation method decocting.

Claims (2)

1. the neurasthenic Chinese medicine composition for the treatment of, is characterized in that this Chinese medicine composition made by the Chinese medicine of following weight portion: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 7-9 part, Rhizoma et radix valerianae 8-10 part, Lignum Poria 6-12 part, Fructus sarcococcae ruscifoliae 8-12 part, Fructus Rubi obcordati 7-9 part, Herba Crotalariae Ferrugineae 7-11 part, Fructus Akebiae 7-9 part, pulvis ferri (ferrosic oxide) 7-12 part, Fructus Melodini Henryi 10-14 part, Herba Ainsliaeae Glabrae 10-14 part, Placenta Hominis 10-14 part, Radix Glycyrrhizae 6-10 part.
2. a kind of neurasthenic Chinese medicine composition for the treatment of according to claim 1, is characterized in that this Chinese medicine composition made by the Chinese medicine of following weight portion: 8 parts of Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.), 9 parts of Rhizoma et radix valerianaes, 9 parts of Lignum Porias, 10 parts of Fructus sarcococcae ruscifoliae, 8 parts of Fructus Rubi obcordatis, 9 parts of Herba Crotalariae Ferrugineaes, 8 parts of Fructus Akebiae, 9.5 parts of pulvis ferri (ferrosic oxide), 12 parts of Fructus Melodini Henryis, 12 parts of Herba Ainsliaeae Glabrae, 12 parts of Placenta Hominiss, 8 parts, Radix Glycyrrhizae.
CN201310467243.1A 2013-09-23 2013-09-23 One treats neurasthenic Chinese medicine composition Expired - Fee Related CN103494904B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310467243.1A CN103494904B (en) 2013-09-23 2013-09-23 One treats neurasthenic Chinese medicine composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310467243.1A CN103494904B (en) 2013-09-23 2013-09-23 One treats neurasthenic Chinese medicine composition

Publications (2)

Publication Number Publication Date
CN103494904A true CN103494904A (en) 2014-01-08
CN103494904B CN103494904B (en) 2015-07-29

Family

ID=49860227

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310467243.1A Expired - Fee Related CN103494904B (en) 2013-09-23 2013-09-23 One treats neurasthenic Chinese medicine composition

Country Status (1)

Country Link
CN (1) CN103494904B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1083719A (en) * 1993-06-09 1994-03-16 苏鉴 Relieving mental strain and helping sleep Chinese patent medicine and preparation method thereof
USPP19942P2 (en) * 2008-03-12 2009-04-21 Gurjit Sidhu Sarcococca plant named ‘Sarsid 1’
CN101780159A (en) * 2010-03-08 2010-07-21 刘彩凤 Preparation method of traditional Chinese medicine for treating insomnia with deficiency of both heart-qi and gallbladder-qi

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1083719A (en) * 1993-06-09 1994-03-16 苏鉴 Relieving mental strain and helping sleep Chinese patent medicine and preparation method thereof
USPP19942P2 (en) * 2008-03-12 2009-04-21 Gurjit Sidhu Sarcococca plant named ‘Sarsid 1’
CN101780159A (en) * 2010-03-08 2010-07-21 刘彩凤 Preparation method of traditional Chinese medicine for treating insomnia with deficiency of both heart-qi and gallbladder-qi

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
刘淑兰等,: "中药紫河车的临床应用", 《中国中药杂志》, vol. 20, no. 1, 31 December 1995 (1995-12-31), pages 55 - 56 *
姜佐宁: "神经衰弱的诊断和治疗", 《赤脚医生杂志》, no. 02, 31 December 1977 (1977-12-31), pages 25 - 26 *
王淑梅等,: "复方缬草合剂的制备及质量控制", 《华西药学杂志》, vol. 15, no. 5, 31 December 2000 (2000-12-31), pages 400 *

Also Published As

Publication number Publication date
CN103494904B (en) 2015-07-29

Similar Documents

Publication Publication Date Title
CN101264275B (en) Medicated pillow for treating scapulohumeral periarthritis and cervical spondylosis
CN103860912B (en) One treats neurasthenic Chinese medicine composition
CN105194631B (en) Treat the Chinese medicine preparation of depression
CN103948708B (en) A kind of Chinese medicine for the treatment of restless legs syndrome
CN103705705A (en) Traditional Chinese medicine composition for treating polymyositis
CN103800888B (en) A kind of Chinese medicine composition treating neurasthenia
CN106110216A (en) Treat neurasthenic Chinese medicinal formulae
CN103933370B (en) A kind of Chinese medicine decoction treating stagnated QI transforming into fire pattern of syndrome cranial tinnitus
CN106075311A (en) One is used for treating neurasthenic Chinese medicine composition
CN102687967A (en) Hypertension medicinal pillow
CN104771652A (en) Vertigo treating traditional Chinese medicine composition
CN103494904B (en) One treats neurasthenic Chinese medicine composition
CN105535849A (en) Traditional Chinese medicine for treating liver depression insomnia
CN104524235A (en) Traditional Chinese medicine composition for treating cardiac neurosis
CN104547642A (en) Tradtional Chinese medicine composition for treating female fibromyalgia syndromes
CN103610856A (en) Traditional Chinese medicine preparation for treating neurasthenia
CN104758652A (en) Traditional Chinese medicine composition for treating dizziness
CN104606650A (en) Traditional Chinese medicine composition treating insomnia
CN101653495B (en) Chinese traditional medicine for curing insomnia
CN103169890B (en) Coordination application of traditional Chinese medicine in social phobia psychotherapy
CN106075060A (en) One treats neurasthenic Chinese medicine composition
CN102274337B (en) Chinese medicinal medicament for treating angioneurotic headache
CN105943753A (en) Traditional Chinese medicinal composition for preventing and treating chronic fatigue syndrome
CN104258176A (en) Traditional Chinese medicine preparation for treating vegetative nerve functional disorder
CN105943999A (en) Pharmaceutical composition for treating wind-phlegm collateral obstruction type ischemic stroke

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150729

Termination date: 20150923

EXPY Termination of patent right or utility model